Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.00
-0.17 (-0.94%)
At close: Oct 8, 2025, 4:00 PM EDT
18.30
+0.30 (1.67%)
After-hours: Oct 8, 2025, 5:42 PM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $982.13 million as of October 8, 2025. Its market cap has decreased by -29.49% in one year.
Market Cap
982.13M
Enterprise Value
557.58M
1-Year Change
-29.49%
Ranking
Category
Stock Price
$18.00
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $982.13M, an increase of 5.41%. That is a compound annual growth rate of 5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 991.41M | 4.59% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.67B |
| Johnson & Johnson | 455.27B |
| AbbVie | 409.05B |
| UnitedHealth Group | 335.73B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.53B |